$4.48
0.44%
Nasdaq, Sep 28, 04:00 pm EDT. Closed.
ISIN
US89455T1097
Symbol
TMCI

Treace Medical Concepts Inc Target price 2026 - Analyst rating & recommendation

Treace Medical Concepts Inc Classifications & Recommendation

Buy
10%
Hold
50%
Sell
40%

Treace Medical Concepts Inc Price Target

Target Price $5.10
Price $4.48
Potential
Number of Estimates 5
5 Analysts have issued a price target Treace Medical Concepts Inc 2027 . The average Treace Medical Concepts Inc target price is $5.10. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 1 Analysts recommend Treace Medical Concepts Inc to buy, 5 to hold and 4 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Treace Medical Concepts Inc stock has an average upside potential 2027 of . Most analysts recommend the Treace Medical Concepts Inc stock at Hold.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Million $ 212.69 211.64
1.59% 0.49%
EBITDA Margin -20.47% -2.07%
9.35% 89.89%
Net Margin -27.74% -26.62%
4.19% 4.04%

7 Analysts have issued a sales forecast Treace Medical Concepts Inc 2026 . The average Treace Medical Concepts Inc sales estimate is

$212m
unlock
. This is
3.08% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$218m 6.38%
unlock
, the lowest is
$202m 1.48%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $213m 1.59%
2026
$212m 0.49%
unlock
2027
$226m 6.82%
unlock
2028
$241m 6.70%
unlock

7 Analysts have issued an Treace Medical Concepts Inc EBITDA forecast 2026. The average Treace Medical Concepts Inc EBITDA estimate is

$-4.4m
unlock
. This is
90.90% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-4.1m 91.48%
unlock
, the lowest is
$-4.9m 89.81%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-43.5m 7.91%
2026
$-4.4m 89.94%
unlock
2027
$-435k 90.08%
unlock
2028
$6.0m 1,487.34%
unlock

EBITDA Margin

2025 -20.47% 9.35%
2026
-2.07% 89.89%
unlock
2027
-0.19% 90.82%
unlock
2028
2.50% 1,415.79%
unlock

7 Treace Medical Concepts Inc Analysts have issued a net profit forecast 2026. The average Treace Medical Concepts Inc net profit estimate is

$-56.3m
unlock
. This is
5.34% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-56.0m 5.85%
unlock
, the lowest is
$-56.6m 4.86%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-59.0m 5.85%
2026
$-56.3m 4.51%
unlock
2027
$-51.3m 8.95%
unlock
2028
$-46.2m 9.98%
unlock

Net Margin

2025 -27.74% 4.19%
2026
-26.62% 4.04%
unlock
2027
-22.69% 14.76%
unlock
2028
-19.14% 15.65%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -0.93 -0.87
3.33% 6.45%
P/E negative
EV/Sales 1.44

7 Analysts have issued a Treace Medical Concepts Inc forecast for earnings per share. The average Treace Medical Concepts Inc EPS is

$-0.87
unlock
. This is
6.45% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$-0.87 6.45%
unlock
, the lowest is
$-0.86 7.53%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.93 3.33%
2026
$-0.87 6.45%
unlock
2027
$-0.79 9.20%
unlock
2028
$-0.71 10.13%
unlock

P/E ratio

Current -4.82 42.86%
2026
-5.17 7.32%
unlock
2027
-5.67 9.67%
unlock
2028
-6.30 11.11%
unlock

Based on analysts' sales estimates for 2026, the Treace Medical Concepts Inc stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.49 21.58%
2026
1.44 3.30%
unlock
2027
1.35 6.38%
unlock
2028
1.26 6.28%
unlock

P/S ratio

Current 1.42 27.90%
2026
1.38 2.99%
unlock
2027
1.29 6.38%
unlock
2028
1.21 6.28%
unlock

Current Treace Medical Concepts Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Truist Securities
Locked
➜
Locked
Locked Aug 10 2026
Truist Securities
Locked
➜
Locked
Locked Jul 16 2026
Lake Street
Locked
➜
Locked
Locked Mar 02 2026
Stifel
Locked
➜
Locked
Locked Jan 07 2026
Truist Securities
Locked
➜
Locked
Locked Dec 18 2025
Truist Securities
Locked
➜
Locked
Locked Nov 10 2025
UBS
Locked
➜
Locked
Locked Nov 07 2025
Analyst Rating Date
Locked
Truist Securities:
Locked
➜
Locked
Aug 10 2026
Locked
Truist Securities:
Locked
➜
Locked
Jul 16 2026
Locked
Lake Street:
Locked
➜
Locked
Mar 02 2026
Locked
Stifel:
Locked
➜
Locked
Jan 07 2026
Locked
Truist Securities:
Locked
➜
Locked
Dec 18 2025
Locked
Truist Securities:
Locked
➜
Locked
Nov 10 2025
Locked
UBS:
Locked
➜
Locked
Nov 07 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today